Literature DB >> 31785720

Opioid-free anesthesia.

Helene Beloeil1.   

Abstract

Opioid-free anesthesia (OFA) is emerging as a new stimulating research perspective. The rationale to propose OFA is based on the aim to avoid the negative impact of intraoperative opioid on a patient's postoperative outcomes and also on the physiology of pathways involved in intraoperative nociception. It is based on the concept of multimodal anesthesia. OFA has been shown to be feasible but the literature is still scarce on the clinically meaningful benefits for patients as well as on the side effects and/or complications that might be associated with it. This review focused first on the physiology of nociception, the reasons for using or not using opioids during anesthesia, and then on the literature reporting evidence-based proofs of benefits/risks associated with OFA.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  alpha 2 agonists; ketamine; lidocaine; opioid; opioid-free anesthesia

Mesh:

Substances:

Year:  2019        PMID: 31785720     DOI: 10.1016/j.bpa.2019.09.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Anaesthesiol        ISSN: 1521-6896


  10 in total

1.  Analgesic Efficacy of Multiple Single-Shot Peripheral Nerve Blocks on Postoperative Short-Term Opioid Usage and Clinical Outcomes in a Suburban Hospital Setting.

Authors:  James Soler; Ned Sciortino; Sara Badaglialacqua; Craig Ryan; Greg Marchand
Journal:  J Clin Med Res       Date:  2022-06-27

2.  Drivers of in-hospital opioid consumption in patients undergoing lumbar fusion surgery.

Authors:  Yoji Ogura; Jeffrey L Gum; Portia Steele; Charles H Crawford; Mladen Djurasovic; R Kirk Owens; Joseph Laratta; Morgan Brown; Christy Daniels; John R Dimar; Steven D Glassman; Leah Y Carreon
Journal:  J Spine Surg       Date:  2021-03

Review 3.  New Insights Into the Pharmacological Management of Postoperative Pain: A Narrative Review.

Authors:  Victor Mayoral Rojals; Moises Charaja; Oscar De Leon Casasola; Antonio Montero; Marco Antonio Narvaez Tamayo; Giustino Varrassi
Journal:  Cureus       Date:  2022-03-10

4.  An Opioid-Sparing Strategy for Laparoscopic Sleeve Gastrectomy: A Retrospective Matched Case-Controlled Study in China.

Authors:  Yuanyuan Ma; Di Zhou; Yu Fan; Shengjin Ge
Journal:  Front Pharmacol       Date:  2022-06-14       Impact factor: 5.988

5.  Analgesic and Anesthetic Efficacy of Rocuronium/Sugammadex in Otorhinolaryngologic Surgery: A Propensity Score-Matched Analysis.

Authors:  En-Bo Wu; Chao-Ting Hung; Sheng-Dean Luo; Shao-Chun Wu; Tsung-Yang Lee; Jo-Chi Chin; Peng-Neng Tsai; Johnson Chia-Shen Yang
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-19

6.  A Study on the Preventive Effect of Esketamine on Postpartum Depression (PPD) after Cesarean Section.

Authors:  Qiwei Wang; Maoxin Xiao; Hao Sun; Pengcheng Zhang
Journal:  Comput Math Methods Med       Date:  2022-08-08       Impact factor: 2.809

7.  Opioid-free total intravenous anesthesia for thyroid and parathyroid surgery: Protocol for a randomized, double-blind, controlled trial.

Authors:  Dan Wang; Yu-Qin Long; Yan Sun; Ya-Juan Zhu; Xiao-Mei Feng; Hong Liu; Fu-Hai Ji; Ke Peng
Journal:  Front Med (Lausanne)       Date:  2022-08-30

8.  Opioid-free anesthesia-dexmedetomidine as adjuvant in erector spinae plane block: a case series.

Authors:  Antonio Coviello; Danilo Esposito; Roberta Galletta; Alfredo Maresca; Giuseppe Servillo
Journal:  J Med Case Rep       Date:  2021-05-29

Review 9.  Opioid-Free Anesthesia Benefit-Risk Balance: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Arthur Salomé; Hakim Harkouk; Dominique Fletcher; Valeria Martinez
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

10.  Combined opioid free and loco-regional anaesthesia enhances the quality of recovery in sleeve gastrectomy done under ERAS protocol: a randomized controlled trial.

Authors:  Mohamed Ibrahim; Ali M Elnabtity; Ahmed Hegab; Omar A Alnujaidi; Osama El Sanea
Journal:  BMC Anesthesiol       Date:  2022-01-21       Impact factor: 2.217

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.